The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 23, 2019

Filed:

May. 20, 2016
Applicant:

Can-fite Biopharma Ltd., Petach Tikva, IL;

Inventor:

Pnina Fishman, Herzliya, IL;

Assignee:

CAN-FITE BIOPHARMA LTD., Petach Tikva, IL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/04 (2006.01); A61K 31/70 (2006.01); A61K 31/7076 (2006.01); A61K 31/00 (2006.01); A61K 31/519 (2006.01); A61K 9/00 (2006.01); A61K 31/706 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7076 (2013.01); A61K 9/0053 (2013.01); A61K 31/00 (2013.01); A61K 31/519 (2013.01); A61K 31/706 (2013.01); A61K 45/06 (2013.01);
Abstract

Provided is an Aadenosine receptor agonist (AAR agonist) for the preparation of a pharmaceutical composition for the treatment of a mammal subject having osteoarthritis (OA), as well as to a method for the treatment of OA in a mammal subject, the method includes administering to said subject in need of said treatment an amount of AAR agonist, the amount being effective to treat or prevent the development of OA. Preferred but not exclusive AAR agonists in accordance with the present subject matter are IB-MECA and Cl-IB-MECA. The AAR agonist may be administered in combination with another drug, such as Methotrexate (MTX). Also provided are pharmaceutical compositions for treatment of osteoarthritis including an amount of an AAR agonist.


Find Patent Forward Citations

Loading…